CompanyDrug

Humanwell Healthcare’s RFUS-144 Wins NMPA Approval for Pruritus Clinical Study

CompanyDeals

Brii Biosciences Partners with Huarun Medicine to Commercialize COVID-19 Antibody Cocktail in China

CompanyDrug

Hengrui Medicine Launches Revelutamide for Metastatic Prostate Cancer in China

CompanyDeals

Chongqing Lummy Pharma Cancels YZY Biopharma Y400 Partnership, Secures Compensation

Drug

HutchMed Initiates Phase I Study of CD47 Monoclonal Antibody HMPL-A83 in China

CompanyDeals

Grand Pharma Acquires Stake in Xeltis and Licenses aXess for Hemodialysis in Greater China

CompanyDeals

Fermion Secures Series B Financing to Advance AI-Driven Drug Development

CompanyDeals

Biotree Raises $14.8M in Series A Financing to Expand Multi-Omics Platform

CompanyDrug

Kexing Pharmaceutical’s SHEN26 COVID-19 Drug Receives NMPA Approval for Clinical Trials

CompanyDeals

WeDoctor Partners with Jinan Innovation Zone to Launch Dual Healthcare Platform

CompanyDrug

ImmuneOnco’s IMM2902 Receives FDA Fast-Track Designation for CD47/HER2 Targeting

Policy / Regulatory

VBP Round 7 Drug Procurement Contract Awards Top Winners Revealed